๐Ÿ“–
Screening for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes patients using the fibrosis-4 score in medina-retrospective study.
Almohammadi MA, Alsadi ZE, Alenezi AB, Ahmed FM, Ahmed BM, Mulla RM, Alrehaili NM, Alsaedi YA, Alhuwayfi AS, Surrati AM

Screening for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes patients using the fibrosis-4 score in medina-retrospective study.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in PeerJ.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Screening for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes patients using the fibrosis-4 score in medina-retrospective study.
Author / Organization Almohammadi MA, Alsadi ZE, Alenezi AB, Ahmed FM, Ahmed BM, Mulla RM, Alrehaili NM, Alsaedi YA, Alhuwayfi AS, Surrati AM
Subject & Discipline PeerJ
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-6579
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »